Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Rectal Neoplasms 2Pain 2Osteoporosis 2Neurotoxicity Syndromes 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Prostatic Neoplasms 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Arthralgia 1

Interventions

Zoledronic Acid 8Letrozole 4Vitamin D 3Calcium 3Risedronic Acid 2Nutrition Assessment 2Denosumab 2Cholecalciferol 2Calcium Gluconate 2Calcium Carbonate 2Aromatase Inhibitors 2parathyroid hormone-related peptide (1-36) 1Technetium 1Resistance Training 1Radiotherapy 1Observation 1Kyphoplasty 1Ibandronic Acid 1Gonadotropin-Releasing Hormone 1Geritol 1Calcium Citrate 1Anastrozole 1Alendronate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Osteoporosis × Calcium Gluconate × Clear all
NCT00058188 2020-12-08

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

Northwestern University

Phase 3 Terminated
53 enrolled
Genitourinary

Osteoporosis, Prostatic Neoplasms

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡